Tiziana Life Sciences Ltd (TLSA)
NASDAQ: TLSA · Real-Time Price · USD
0.907
-0.033 (-3.49%)
At close: Nov 4, 2024, 4:00 PM
0.910
+0.003 (0.30%)
After-hours: Nov 4, 2024, 6:43 PM EST
Tiziana Life Sciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Selling, General & Admin | 8.4 | 9.87 | 1.63 | 14.17 | 24.42 | 6.21 | |
| Research & Development | 7.4 | 8.11 | 12.96 | 13.21 | 5.99 | 3.71 | |
| Operating Expenses | 15.8 | 17.98 | 14.59 | 27.37 | 30.41 | 9.92 | |
| Operating Income | -15.8 | -17.98 | -14.59 | -27.37 | -30.41 | -9.92 | |
| Interest Expense | -0.01 | -0.01 | -0.01 | -0.18 | -0.32 | -0.09 | |
| Interest & Investment Income | 1.27 | 1.15 | 0.03 | - | 0.01 | 0 | |
| Other Non Operating Income (Expenses) | - | - | 0.03 | 0.89 | - | - | |
| EBT Excluding Unusual Items | -14.54 | -16.84 | -14.53 | -26.66 | -30.72 | -10.01 | |
| Gain (Loss) on Sale of Investments | -2.07 | -0.4 | -0.87 | - | - | - | |
| Gain (Loss) on Sale of Assets | - | - | - | - | 2.66 | - | |
| Asset Writedown | - | - | - | - | -0.28 | - | |
| Pretax Income | -16.61 | -17.24 | -15.4 | -26.66 | -28.34 | -10.01 | |
| Income Tax Expense | -2.88 | 0.45 | - | -3.24 | -2.21 | -0.69 | |
| Net Income | -13.73 | -17.69 | -15.4 | -23.42 | -26.13 | -9.32 | |
| Net Income to Common | -13.73 | -17.69 | -15.4 | -23.42 | -26.13 | -9.32 | |
| Shares Outstanding (Basic) | 103 | 102 | 102 | 98 | 97 | 97 | |
| Shares Outstanding (Diluted) | 103 | 102 | 102 | 98 | 97 | 97 | |
| Shares Change (YoY) | -0.78% | 0.93% | 3.67% | 0.64% | - | -23.71% | |
| EPS (Basic) | -0.13 | -0.17 | -0.15 | -0.24 | -0.27 | -0.10 | |
| EPS (Diluted) | -0.13 | -0.17 | -0.15 | -0.24 | -0.27 | -0.10 | |
| Free Cash Flow | -3.92 | -15.7 | -19.62 | -21.78 | -11.34 | -6.8 | |
| Free Cash Flow Per Share | -0.04 | -0.15 | -0.19 | -0.22 | -0.12 | -0.07 | |
| EBITDA | -15.79 | -17.98 | -14.59 | -27.37 | -30.41 | -9.92 | |
| D&A For EBITDA | 0.01 | 0.01 | 0 | 0.01 | 0.01 | 0.01 | |
| EBIT | -15.8 | -17.98 | -14.59 | -27.37 | -30.41 | -9.92 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.